Skip to content

Drug interactions

Bortezomib + Rifabutin

Severity: Moderate

Bortezomib and Rifabutin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifabutin is a CYP3A4 inducer and may lower bortezomib exposure, potentially reducing its antimyeloma effect. The induction is weaker than with rifampicin but may still matter.

What this interaction means in plain words

Bortezomib and Rifabutin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bortezomib belongs to Oncology; Rifabutin belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Rifabutin induces CYP3A4, increasing the metabolic clearance of bortezomib.

What to do

Where possible choose an alternative to rifabutin; if it must be used, monitor disease response and consider the clinical implications of reduced bortezomib exposure.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Rifabutin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Rifabutin?

MediHelp rates the interaction as moderate. Bortezomib and Rifabutin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rifabutin is a CYP3A4 inducer and may lower bortezomib exposure, potentially reducing its antimyeloma effect. The induction is weaker than with rifampicin but may still matter.

How serious is the interaction between Bortezomib and Rifabutin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible choose an alternative to rifabutin; if it must be used, monitor disease response and consider the clinical implications of reduced bortezomib exposure.

What other medicines interact with Bortezomib?

MediHelp also lists interactions of Bortezomib with, for example, Apalutamide, Carbamazepine, Etrasimod. The full list is on the Bortezomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in